Industry News

• Synthetic Biologics prices $18,000,000 public offering Synthetic Biologics announced pricing of an underwritten public offering with expected total gross proceeds of $18,000,000. The Company expects to use the net proceeds to fund its and its subsidiaries' preclinical and clinical programs and for working capital and general corporate purposes.
  October 11, 2018

More...